Drawing for GENETICALLY ENGINEERED MICROBIAL MEDICINE

USPTO serial 98143058

GENETICALLY ENGINEERED MICROBIAL MEDICINE

Reviewed by CopyMark Law Group

Status 651
Filing date
Status date
Registration date
—
Examiner
LAW, CHRISTOPHER M
Law office
TMEG LAW OFFICE 103

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GENETICALLY ENGINEERED MICROBIAL MEDICINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brent Capehart

Brent Capehart PALMER IP INC.704-1478 WEST HASTINGS STREETVANCOUVER, BC, V6G3J6CANADA

Goods and services

ClassDescriptionStatusFirst use
005Medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of mental health disorders; probiotic bacterial formulations for medical purposes; probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive systemACTIVE—
035Business administration of medication reimbursement programs and services; administration and management of research grants; business administration of prescription drug programs designed to process medical insurance claims for products used by consumers; business administration of prescription drug programs designed to process medical insurance claims for services used by consumers; business administrative services for medical referrals; advertising services for promoting public awareness of the benefits of general health and wellness; advertising services for promoting public awareness of the benefits of nutrition; advertising services to promote public awareness of medical conditions; advertising services to promote public awareness on health issues; advertising services to promote public awareness on healthcare issues; analysis of market research data and statistics; providing business assistance to others in preparing and filing applications for new drugs with governmental regulatory bodies; business administration of a program to provide access to medicines at low or no cost to underserved populations; business administration of a program to provide discounts on prescription medicines; business administration of medication reimbursement programs and services; business mediation of agreements and contracts for the purchase and sale of health preparations for medical purposes; collection and compilation of medical report information into databases; compilation of medical reports; compilation of statistical data into databases in the field of scientific or medical research; consulting services in the field of administrative processing of health insurance claims for health insurers, administrators and payers; consulting services in the field of medical product approval for commercial purposes; consulting services in the field of patient relationship management for healthcare providers; market analysis; market analysis and research; market assessment consultancy; market assessment services; preparation of market reports; conducting market studies; market research consultancy; market research services; market research studies; market studies; medical billing; medical billing support services; medical cost management; medical records coding services for others for purposes of reimbursement from insurance; business administrative services for medical referrals; on-line retail store services featuring dietary supplements; on-line retail store services featuring dietetic preparations; on-line wholesale store services featuring dietary supplements; on-line wholesale store services featuring dietetic preparations; online and retail store services featuring of prescription drugsACTIVE—
039Delivery of prescription drugsACTIVE—
042Medical, scientific and veterinary research, namely clinical trials; conducting interventional clinical studies; pharmaceutical drug development services for others; pharmaceutical product evaluation; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific research information in the fields of pharmaceuticals; medical, scientific and veterinary research in the fields of clinical trials and post-market trials; research on the subject of pharmaceuticals; scientific research for the development of CRISPR-based platforms and products in the field of genetic engineeringACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 20, 2026GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Oct 20, 2026CNSISUSPENSION INQUIRY WRITTEN—
Oct 14, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 16, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Aug 14, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 10, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 24, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 24, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Jul 24, 2024CNSLSUSPENSION LETTER WRITTEN—
Jul 18, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 18, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 18, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 19, 2024DOCKASSIGNED TO EXAMINER—
Sep 20, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 25, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance